• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树状聚合物纳米杂化载体系统:靶向药物和基因递送的广阔前景。

Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery.

机构信息

Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.

Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Kishangarh, Ajmer 305801, India.

出版信息

Drug Discov Today. 2018 Feb;23(2):300-314. doi: 10.1016/j.drudis.2017.06.009. Epub 2017 Jul 8.

DOI:10.1016/j.drudis.2017.06.009
PMID:28697371
Abstract

Highly controllable dendritic structural design means dendrimers are a leading carrier in drug delivery applications. Dendrimer- and other nanocarrier-based hybrid systems are an emerging platform in the field of drug delivery. This review is a compilation of increasing reports of dendrimer interactions, such as dendrimer-liposome, dendrimer-carbon-nanotube, among others, known as hybrid carriers. This should prompt entirely new research with promising results for these hybrid carriers. It is assumed that such emerging hybrid nanosystems - from combining two already-established drug delivery platforms - could lead the way for the development of newer delivery systems with multiple applicability for latent theranostic applications in the future.

摘要

高度可控的树枝状结构设计意味着树枝状大分子是药物传递应用中的主要载体。树枝状大分子和其他基于纳米载体的混合系统是药物传递领域的一个新兴平台。本综述汇集了越来越多的关于树枝状大分子相互作用的报道,例如树枝状大分子-脂质体、树枝状大分子-碳纳米管等,这些都被称为混合载体。这应该会促使对这些混合载体进行全新的研究,并取得有前景的结果。可以假设,这种新兴的混合纳米系统——将两种已经确立的药物传递平台结合起来——可能为未来更具多种适用性的潜在治疗诊断应用的新型传递系统的发展开辟道路。

相似文献

1
Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery.树状聚合物纳米杂化载体系统:靶向药物和基因递送的广阔前景。
Drug Discov Today. 2018 Feb;23(2):300-314. doi: 10.1016/j.drudis.2017.06.009. Epub 2017 Jul 8.
2
Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs.用于理解树枝状纳米颗粒与药物络合作用的药物信息学方法。
Nanoscale. 2014 Mar 7;6(5):2476-501. doi: 10.1039/c3nr05400d. Epub 2014 Jan 20.
3
Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer.脂质-树枝状聚合物杂化纳米系统作为紫杉醇治疗卵巢癌的新型给药系统。
J Control Release. 2015 Dec 28;220(Pt A):438-446. doi: 10.1016/j.jconrel.2015.11.004. Epub 2015 Nov 7.
4
Dendrimer-surfactant interactions.树枝状大分子-表面活性剂相互作用。
Soft Matter. 2014 Apr 28;10(16):2714-27. doi: 10.1039/c3sm53180e.
5
Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.用于药物递送的树枝状大分子及药物-树枝状大分子缀合物的合成。
Curr Opin Drug Discov Devel. 2007 Nov;10(6):756-67.
6
Pharmaceutical and biomedical potential of surface engineered dendrimers.表面工程树枝状大分子的药学与生物医学潜力
Crit Rev Ther Drug Carrier Syst. 2007;24(3):257-306. doi: 10.1615/critrevtherdrugcarriersyst.v24.i3.20.
7
Nanoparticle-cored dendrimers: functional hybrid nanocomposites as a new platform for drug delivery systems.纳米核树突状聚合物:作为药物传递系统新平台的功能杂化纳米复合材料。
Nanoscale. 2015 Mar 7;7(9):3808-16. doi: 10.1039/c4nr04438j.
8
Application of Dendrimers in Anticancer Diagnostics and Therapy.树状高分子在癌症诊断与治疗中的应用。
Molecules. 2022 May 18;27(10):3237. doi: 10.3390/molecules27103237.
9
Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics.作为神经治疗诊断纳米载体的聚合物树枝状大分子
Small. 2022 Nov;18(45):e2203629. doi: 10.1002/smll.202203629. Epub 2022 Sep 9.
10
Host-guest chemistry of dendrimer-drug complexes. 3. Competitive binding of multiple drugs by a single dendrimer for combination therapy.树状大分子-药物配合物的主-客体化学。3. 单一树状大分子对多种药物的竞争结合用于联合治疗。
J Phys Chem B. 2009 Oct 29;113(43):14172-9. doi: 10.1021/jp907437e.

引用本文的文献

1
Phytosomes-unraveling the Unique Properties of Plant-derived Nanotechnological Drug Delivery Systems: A Review.植物脂质体——解析植物源纳米技术药物递送系统的独特性质:综述
Curr Med Chem. 2025 Jan 24. doi: 10.2174/0109298673319759250116104648.
2
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
3
Aerosol Inhalation of Gene Delivery Therapy for Pulmonary Diseases.气溶胶吸入基因传递疗法治疗肺部疾病。
Biomolecules. 2024 Jul 25;14(8):904. doi: 10.3390/biom14080904.
4
Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis.变革中风护理:基于纳米技术的脑递送作为治疗和诊断的新范式
Mol Neurobiol. 2025 Jan;62(1):184-220. doi: 10.1007/s12035-024-04215-3. Epub 2024 Jun 3.
5
Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy.了解纳米铁死亡用于癌症治疗的新方法。
Nanomicro Lett. 2024 May 2;16(1):188. doi: 10.1007/s40820-024-01399-0.
6
Recent Advances in Kaolinite Nanoclay as Drug Carrier for Bioapplications: A Review.高岭石纳米粘土作为生物应用药物载体的最新进展:综述。
Adv Sci (Weinh). 2023 Sep;10(25):e2300672. doi: 10.1002/advs.202300672. Epub 2023 Jun 21.
7
Emerging biomaterials for tumor immunotherapy.用于肿瘤免疫治疗的新型生物材料。
Biomater Res. 2023 May 16;27(1):47. doi: 10.1186/s40824-023-00369-8.
8
Advancements in nanoparticle-based treatment approaches for skin cancer therapy.基于纳米粒子的皮肤癌治疗方法的进展。
Mol Cancer. 2023 Jan 12;22(1):10. doi: 10.1186/s12943-022-01708-4.
9
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer.解析 siRNA 和适体介导的疗法对抗胰腺癌的奥秘。
Mol Cancer. 2023 Jan 12;22(1):8. doi: 10.1186/s12943-022-01696-5.
10
Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy.适体作为癌症治疗中靶向药物递送的智能配体。
Pharmaceutics. 2022 Nov 22;14(12):2561. doi: 10.3390/pharmaceutics14122561.